Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Itolizumab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Equillium Announces Interim EQUATOR GVHD Enrollment Achieved
    Equillium Announces Interim EQUATOR GVHD Enrollment Achieved

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514537675/en

    BUSINESSWIRE
    14 May 2024
    Share Share
    Equillium Announces Positive Data from the Ph 1b EQUALISE study
    Equillium Announces Positive Data from the Ph 1b EQUALISE study

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401373328/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share
    Equillium delivers new lupus data to Ono's doorstep
    Equillium delivers new lupus data to Ono's doorstep

    01 Apr 2024

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/equlliums-lupus-candidate-delivers-new-data-teeing-opt-decision-ono

    Max Bayer FIERCE BIOTECH
    01 Apr 2024
    Share Share
    Biocon starts clinical study to evaluate efficacy of Itolizumab
    Biocon starts clinical study to evaluate efficacy of Itolizumab

    15 Dec 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-starts-clinical-study-to-evaluate-efficacy-of-itolizumab/articleshow/96243936.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    15 Dec 2022
    Share Share
    Equillium and Ono Pharmaceutical Announce Agreement for Itolizumab
    Equillium and Ono Pharmaceutical Announce Agreement for Itolizumab

    06 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221206005379/en

    BUSINESSWIRE
    06 Dec 2022
    Share Share
    Equillium Reports Second Quarter 2022 Financial Results
    Equillium Reports Second Quarter 2022 Financial Results

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005539/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share